Ewen Sedman
4Patents
2h-index
4Co-inventors
33Inventor score
Filing activity: May 16, 2000 → Nov 28, 2007
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7642261B2 | Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts | Human Necessities | 9 | Active |
| US6900212B1 | Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts | Human Necessities | 4 | Expired |
| US7479492B2 | Use combined 5-HT1A agonists and selective serotonin reuptake inhibitors | Human Necessities | 0 | Expired |
| US7371756B2 | Use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.